Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Improvement of the Dengue Virus (DENV) Nonhuman Primate Model via a Reverse Translational Approach Based on Dengue Vaccine Clinical Efficacy Data against DENV-2 and -4.

Barban V, Mantel N, De Montfort A, Pagnon A, Pradezynski F, Lang J, Boudet F.

J Virol. 2018 May 29;92(12). pii: e00440-18. doi: 10.1128/JVI.00440-18. Print 2018 Jun 15.

2.

Cytokine Profile of Children Hospitalized with Virologically-Confirmed Dengue during Two Phase III Vaccine Efficacy Trials.

Harenberg A, de Montfort A, Jantet-Blaudez F, Bonaparte M, Boudet F, Saville M, Jackson N, Guy B.

PLoS Negl Trop Dis. 2016 Jul 26;10(7):e0004830. doi: 10.1371/journal.pntd.0004830. eCollection 2016 Jul.

3.

A bivalent pneumococcal histidine triad protein D-choline-binding protein A vaccine elicits functional antibodies that passively protect mice from Streptococcus pneumoniae challenge.

Ochs MM, Williams K, Sheung A, Lheritier P, Visan L, Rouleau N, Proust E, de Montfort A, Tang M, Mari K, Hopfer R, Gallichan S, Brookes RH.

Hum Vaccin Immunother. 2016 Nov;12(11):2946-2952.

4.

Phosphate substitution in an AlOOH - TLR4 adjuvant system (SPA08) modulates the immunogenicity of Serovar E MOMP from Chlamydia trachomatis.

Visan L, Sanchez V, Kania M, de Montfort A, de la Maza LM, Ausar SF.

Hum Vaccin Immunother. 2016 Sep;12(9):2341-50. doi: 10.1080/21645515.2016.1168958. Epub 2016 Apr 22.

5.

Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs.

Bernard MC, Barban V, Pradezynski F, de Montfort A, Ryall R, Caillet C, Londono-Hayes P.

PLoS One. 2015 Apr 2;10(4):e0121518. doi: 10.1371/journal.pone.0121518. eCollection 2015.

6.

Avian glycan-specific IgM monoclonal antibodies for the detection and quantitation of type A and B haemagglutinins in egg-derived influenza vaccines.

Legastelois I, Chevalier M, Bernard MC, de Montfort A, Fouque M, Pilloud A, Serraille C, Devard N, Engel O, Sodoyer R, Moste C.

J Virol Methods. 2011 Dec;178(1-2):129-36. doi: 10.1016/j.jviromet.2011.08.027. Epub 2011 Aug 31.

PMID:
21907241
7.

AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice.

Caillet C, Piras F, Bernard MC, de Montfort A, Boudet F, Vogel FR, Hoffenbach A, Moste C, Kusters I.

Vaccine. 2010 Apr 19;28(18):3076-9. doi: 10.1016/j.vaccine.2010.02.050. Epub 2010 Mar 1.

PMID:
20193791
8.

Memory B and T cell responses induced by serotype 4 Streptococcus pneumoniae vaccines: longitudinal analysis comparing responses elicited by free polysaccharide, conjugate and carrier.

Deauvieau F, Dussurgey S, Rossignol D, de Montfort A, Burdin N, Guy B.

Vaccine. 2009 Dec 11;28(2):576-82. doi: 10.1016/j.vaccine.2009.09.081. Epub 2009 Oct 28.

PMID:
19878751
9.

Innate immune responses in human dendritic cells upon infection by chimeric yellow-fever dengue vaccine serotypes 1-4.

Deauvieau F, Sanchez V, Balas C, Kennel A, DE Montfort A, Lang J, Guy B.

Am J Trop Med Hyg. 2007 Jan;76(1):144-54.

PMID:
17255244

Supplemental Content

Loading ...
Support Center